COc1cc(CNC(=O)c2cnc3c(-c4cccc(C)c4)c(C)nn3c2C)cc(OC)c1OC
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?